By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Hikma Pharmaceuticals 

13 Hanover Square

London    W1S 1HL  United Kingdom
Phone: 44-0-20-7399-2760 Fax: 44-0-20-7399-2761



Company News
Xellia Expands U.S. Production With Acquisition Of Manufacturing Plant From Hikma (HIK.L) 11/25/2015 10:22:30 AM
Hikma (HIK.L) Announces Successful Resolution To FDA Warning Letter At Its Portugal Facility 11/18/2015 10:16:17 AM
Hikma (HIK.L) Launches Phentolamine Mesylate Injection In The U.S. 11/5/2015 9:48:49 AM
Hikma (HIK.L) Signs Exclusive Licensing, Distribution And Supply Agreement With Basilea Pharmaceutica International Ltd. For Zevtera 10/15/2015 11:14:08 AM
Hikma (HIK.L) Interim Results 8/19/2015 9:42:45 AM
Hikma (HIK.L) Snags Boehringer Ingelheim's U.S. Generics Biz for $2.65 Billion 7/28/2015 5:46:08 AM
Hikma (HIK.L) Rumored to Be Bidding $2.2B for Boehringer Ingelheim's Roxane Laboratories, As Mallinckrodt (MNK), Perrigo (PRGO) Circle 6/30/2015 6:06:29 AM
Hikma Pharmaceuticals (HIK.L) Founder And Honorary Life President Samih Darwazah Passes Away 5/18/2015 11:32:35 AM
Hikma Pharmaceuticals (HIK.L) Release: AGM Trading Update 5/14/2015 11:47:39 AM
Hikma Pharmaceuticals (HIK.L) Launches Caffeine Citrate Injection, Commercialising The First Of The Bedford Products 5/12/2015 9:22:01 AM